Corcept Therapeutics reported $37.81M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Ani Pharmaceuticals ANIP:US $ 31.96M 3.14M
Aurora Cannabis Inc ACB:CN 43.17M 3.69M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Canopy Growth Corp WEED:CN C$ 108.85M 1.48M
Corcept Therapeutics CORT:US $ 37.81M 264K
Depomed DEPO:US $ 10.54M 105K
Eleven Biotherapeutics EBIO:US 8.98M 379K
Eli Lilly And LLY:US $ 1.63B 67.2M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Johnson & Johnson JNJ:US $ 6.23B 288M
Lannett LCI:US $ 17.57M 1.22M
Lexicon Pharmaceuticals LXRX:US 10.69M 2.19M
Merk MRK:US $ 2.42B 118M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Novartis NOVN:VX 3.59B 91M
Novartis NVS:US 3.59B 91M
Pacira Pharmaceuticals PCRX:US $ 65M 743K
Pfizer PFE:US $ 3.2B 506M
Supernus Pharmaceuticals SUPN:US $ 100.48M 10.02M
Tg Therapeutics TGTX:US $ 12.64M 7.97M
Ziopharm Oncology ZIOP:US $ 3.5M 1.41M